TWI438005B - Fluorescent gold nanocluster matrix - Google Patents

Fluorescent gold nanocluster matrix Download PDF

Info

Publication number
TWI438005B
TWI438005B TW100149309A TW100149309A TWI438005B TW I438005 B TWI438005 B TW I438005B TW 100149309 A TW100149309 A TW 100149309A TW 100149309 A TW100149309 A TW 100149309A TW I438005 B TWI438005 B TW I438005B
Authority
TW
Taiwan
Prior art keywords
fluorescent
aggregate
gold nano
gold
nano
Prior art date
Application number
TW100149309A
Other languages
Chinese (zh)
Other versions
TW201223546A (en
Inventor
張恒雄
林政鞍
楊婷雅
李志賢
拉爾夫 亞歷山大 士柏林
沃爾夫岡 派瑞克
Original Assignee
中原大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 中原大學 filed Critical 中原大學
Priority to TW100149309A priority Critical patent/TWI438005B/en
Publication of TW201223546A publication Critical patent/TW201223546A/en
Application granted granted Critical
Publication of TWI438005B publication Critical patent/TWI438005B/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Luminescent Compositions (AREA)

Description

螢光金奈米團簇聚集體Fluorescent gold nano cluster aggregate

本發明係關於一種奈米團簇,特別係關於一種螢光金奈米團簇聚集體。The present invention relates to a nanoclusters, and more particularly to a fluorescent gold nanon cluster aggregate.

當金屬或半導體粒子的尺寸足夠小時,將產生量子限制效應,即微粒的電荷和能量是量子化的,這樣的微小粒子團被稱為量子點。量子點電子排列相當緊密,由於量子限量化效應可以激發出不同顏色的螢光,量子點吸收能量較高的光波後產生能階躍升,當電子從高能階的狀態降到低能階的狀態時,會發射出波長較長(偏紅光系)的光。不同粒徑的量子點會發射出不同波長的螢光,例如硒化鎘(CdSe)粒徑在2.1nm時發出藍色螢光,粒徑5nm時發出綠色螢光,當粒徑接近10nm時,它所激發的螢光就接近紅色。When the size of the metal or semiconductor particles is small enough, a quantum confinement effect will be produced, that is, the charge and energy of the particles are quantized, and such tiny clusters are called quantum dots. Quantum dot electrons are arranged very tightly. Because quantum quantification effects can excite different colors of fluorescence, quantum dots absorb energy waves with higher energy and produce energy step jumps. When electrons fall from high-energy state to low-energy state, Light with a longer wavelength (reddish light) is emitted. Quantum dots of different particle sizes emit fluorescence of different wavelengths. For example, cadmium selenide (CdSe) emits blue fluorescence when the particle diameter is 2.1 nm, and green fluorescence when the particle diameter is 5 nm. When the particle size is close to 10 nm, The fluorescence it emits is close to red.

相較於傳統的有機染料分子,量子點具有螢光亮度 強、光穩定性佳、以及用單一波長的雷射便可以激發出多種不同波長的發射波之特性。發射波是一狹窄且對稱的波形,且可重複激發,因此螢光時效可以持久。這些特性吸引科學家的重視,奈米量子點的應用也越來越多樣性,深具取代傳統染劑的潛力,因此,在生醫工程應用方面,更有令人期待的發展性。Quantum dots have fluorescent brightness compared to traditional organic dye molecules Strong, stable light, and the ability to emit a variety of different wavelengths of the wave with a single wavelength of laser. The transmitted wave is a narrow and symmetrical waveform that can be repeatedly excited, so the fluorescence aging can last. These characteristics attract the attention of scientists. The application of nano-quantum dots is becoming more and more diverse, and it has the potential to replace traditional dyes. Therefore, it is more promising in the application of biomedical engineering.

近年來量子點以其優異的光學特性,已成功地克服過去生物及醫學光學探針所面臨之瓶頸,儼然成為新一代螢光探針設計之重要奈米材料。從細胞三維立體影像、長時間活細胞監控、單分子動態胞內追蹤、長效型光學感測器研製、癌症診斷與治療皆有突破性進展,加上量子點快速產業化及其上億商機,已成奈米生物技術極為成功應用之典範。然而傳統市售以鎘或鉛等有毒重金屬材料為主之水溶性量子點,其延伸對環境及人體健康可能帶來的衝擊逐漸受到重視,是目前全面開拓其生醫應用所面臨之窘境。In recent years, quantum dots, with their excellent optical properties, have successfully overcome the bottlenecks faced by biological and medical optical probes in the past, and have become an important nanomaterial for the design of a new generation of fluorescent probes. From the three-dimensional image of cells, long-term live cell monitoring, single-molecule dynamic intracellular tracking, development of long-acting optical sensors, cancer diagnosis and treatment, breakthroughs have been made, coupled with the rapid industrialization of quantum dots and its billion business opportunities. It has become a model for the extremely successful application of nanotechnology. However, traditionally, water-soluble quantum dots based on toxic heavy metal materials such as cadmium or lead are commercially available. The impact of the extension on the environment and human health is gradually being paid attention to, and it is the dilemma facing the full development of its biomedical applications.

金屬金係為研究較早之一種奈米材料,在生物學研究中被稱為膠體金,粒子尺寸在1-100nm之間。金量子點具有很高的電子密度,在電子顯微鏡下有很好的襯度,並且具有相當高之生物相容性,其已被證實經由改變其原子團簇之大小即可發出不同顏色之螢光,能夠應用在多元之生醫標定或光學元件的製作上,但由於製程相當不易,合成時需要利用昂貴的樹狀聚合物(dendrimer)作為金量子 點之包覆材料,耗時且不易大量生產,故限制其廣大生醫應用之開發。因此,開發出簡易並可大量生產製造之金量子點形成技術係產業界亟欲發展之重點。Metal gold is one of the earliest researched nanomaterials. It is called colloidal gold in biological research and its particle size is between 1-100nm. Gold quantum dots have a high electron density, good contrast under an electron microscope, and a relatively high biocompatibility, which has been shown to emit different colors of fluorescence by changing the size of their clusters. It can be applied to the production of multi-dimensional biomedical calibration or optical components, but because the process is quite difficult, it is necessary to use expensive dendrimer as gold quantum. The coating material of the point is time-consuming and difficult to mass-produce, thus limiting the development of its vast biomedical applications. Therefore, the development of a simple and mass-produced gold quantum dot formation technology is the focus of the industry's development.

鑒於上述發明背景中,為了符合產業上之要求,本發明提供螢光金奈米團簇聚集體。In view of the above background of the invention, in order to comply with industrial requirements, the present invention provides a cluster of fluorescent gold nanoclusters.

本發明之特徵的在於提供一種螢光金奈米團簇聚集體(Fluorescent gold nanocluster),上述螢光金奈米團簇表面具有一種二氫硫辛酸(dihydrolipoic acid;DHLA)配體(ligand),其中,上述螢光金奈米團簇係藉由上述二氫硫辛酸配體與上述金奈米團簇間之作用而產生螢光性質,且上述螢光金奈米團簇之粒徑範圍為0.5nm至3nm,此外,上述螢光金奈米團簇之光激螢光波長範圍為400至1000nm。The present invention is characterized in that a fluorescent gold nanocluster is provided, and the surface of the fluorescent gold nano-cluster has a dihydrolipoic acid (DHLA) ligand. Wherein the fluorescent gold nano-cluster is produced by the interaction between the dihydrolipoic acid ligand and the above-mentioned gold nano-cluster, and the particle size range of the fluorescent gold nano-clustered cluster is 0.5 nm to 3 nm, in addition, the above-mentioned fluorescent gold nano clusters have a wavelength of 400 to 1000 nm.

本發明之另一特徵在於提供一種螢光金奈米團簇聚集體(Fluorescent gold nanocluster matrix),上述螢光金奈米團簇聚集體係由複數個金奈米團簇規則堆疊所形成,上述金奈米團簇粒徑範圍為0.5nm至3nm,且上述金奈米團簇表面具有一種烷硫醇(alkanethiol)配體(ligand),其中,各個上述金奈米團簇係透過其表面之烷 硫醇配體間之作用力,相互吸引堆疊以形成上述螢光金奈米團簇聚集體(Fluorescent gold nanocluster matrix),並且,上述螢光金奈米團簇聚集體係藉由上述金奈米團簇之聚集而產生螢光性質,此外,上述螢光金奈米團簇聚集體之光激螢光波長範圍為400至1000nm。Another feature of the present invention is to provide a Fluorescent gold nanocluster matrix, wherein the fluorescent gold nano cluster assembly system is formed by stacking a plurality of gold nanoclusters, the gold The nano-cluster particle size ranges from 0.5 nm to 3 nm, and the surface of the above-mentioned gold nano-clusters has an alkanethiol ligand, wherein each of the above-mentioned gold nano-clusters passes through the surface of the alkane. a force between the thiol ligands, mutually attracting the stack to form the above-mentioned Fluorescent gold nanocluster matrix, and the above-mentioned fluorescent gold nano cluster assembly system by the above-mentioned gold nano-cluster The clustering of the clusters produces a fluorescent property, and in addition, the above-mentioned fluorescent gold nanoparticle aggregates have a photoreceptor wavelength in the range of 400 to 1000 nm.

本發明之又一特徵在於提供一種金屬奈米團簇(metal nanocluster)之形成方法,首先提供一混合溶液,上述混合溶液包含一第一金屬前驅物(metal precursor)、一界面活性劑(surfactant)、一還原劑(reductant)與一溶劑,於上述混合溶液中進行一還原反應以形成一奈米金屬粒子(metal nanoparticle),再者,於形成上述奈米金屬粒子後加入一第二金屬前驅物,使得上述第二金屬前驅物之粒子數大於上述奈米金屬粒子之總數,由於上述奈米金屬粒子與上述第二金屬前驅物之濃度差異甚大,造成一不平衡之並存系統,上述奈米金屬粒子因此崩裂為粒徑較小之金屬奈米團簇(metal nanocluster)以形成一平衡系統,其中,上述金屬奈米團簇之粒徑範圍係為1nm至4nm。Another feature of the present invention is to provide a method for forming a metal nanocluster, which first provides a mixed solution comprising a first metal precursor and a surfactant. And a reducing agent and a solvent are subjected to a reduction reaction in the mixed solution to form a metal nanoparticle, and further, a second metal precursor is added after forming the nano metal particles. So that the number of particles of the second metal precursor is greater than the total number of the nano metal particles, because the concentration of the nano metal particles and the second metal precursor are very different, resulting in an unbalanced coexisting system, the nano metal The particles thus collapse into metal nanoclusters of smaller particle size to form an equilibrium system wherein the metal nanoclusters have a particle size ranging from 1 nm to 4 nm.

根據以上所述之目的,本發明揭示了一種螢光金奈米團簇聚集體及其形成方法,上述之形成方法能應用於各種金屬,據以形成各種金屬奈米團簇。其中,上述之螢光金奈米團簇聚集體能作為生物探針(bioprobes),並具有下 列之應用:生物螢光標記(fluorescent biological label)、臨床醫療影像顯影劑以及臨床醫療檢測、追蹤與治療。In accordance with the above objects, the present invention discloses a fluorescent gold nanon cluster aggregate and a method of forming the same, which can be applied to various metals to form various metal nanoclusters. Wherein, the above-mentioned fluorescent gold nano cluster aggregates can be used as bioprobes and have Applications: fluorescent biological labels, clinical medical imaging agents, and clinical medical testing, tracking and treatment.

本發明在此所探討的方向為一種螢光金奈米團簇聚集體。為了能徹底地瞭解本發明,將提出詳盡的描述說明。顯然地,本發明的施行並未限定於該領域之技藝者所熟習的特殊細節。另一方面,眾所周知的組成或步驟並未描述於細節中,以避免造成本發明不必要之限制。本發明的較佳實施例會詳細描述如下,然而除了這些詳細描述之外,本發明還可以廣泛地施行在其他的實施例中,且本發明的範圍不受限定,其以之後的專利範圍為準。The orientation of the invention discussed herein is a fluorescent gold nanoparticle cluster. In order to fully understand the present invention, a detailed description will be presented. Obviously, the practice of the invention is not limited to the specific details that are apparent to those skilled in the art. On the other hand, well-known components or steps are not described in detail to avoid unnecessarily limiting the invention. The preferred embodiments of the present invention are described in detail below, but the present invention may be widely practiced in other embodiments, and the scope of the present invention is not limited by the scope of the following patents. .

本發明之一實施例係揭露一種螢光金奈米團簇(Fluorescent gold nanocluster),上述螢光金奈米團簇表面具有一種二氫硫辛酸(dihydrolipoic acid;DHLA)配體(ligand),其中,上述螢光金奈米團簇係藉由上述二氫硫辛酸配體與上述奈米團簇間之作用而產生螢光性質,且上述螢光金奈米團簇之粒徑範圍為0.5nm至3nm,此外,上述螢光金奈米團簇之光激螢光波長範圍為400至1000nm。One embodiment of the present invention discloses a Fluorescent gold nanocluster having a dihydrolipoic acid (DHLA) ligand on the surface of the fluorescent gold nano-cluster. The fluorescent gold nano cluster is produced by the interaction between the dihydrolipoic acid ligand and the nano cluster, and the particle size range of the fluorescent gold nano cluster is 0.5 nm. Up to 3 nm, in addition, the above-mentioned fluorescent gold nano-clusters have a wavelength of light-emitting fluorescence ranging from 400 to 1000 nm.

於本實施例之一較佳範例中,上述螢光金奈米團簇更包含一間隔物(spacer),上述間隔物之一端鍵結上述二氫硫辛酸(dihydrolipoic acid;DHLA)配體,且上述間隔物鍵結之另一端有一特定基團,其中,上述間隔物包含寡聚物或高分子,而上述特定基團係包含下列族群中之一者:化學官能基、交聯分子、醣類、螢光分子、順磁性分子、生物分子與藥物。In a preferred embodiment of the present embodiment, the fluorescent gold nano-clusters further comprise a spacer, and one of the spacers is bonded to the dihydrolipoic acid (DHLA) ligand, and The other end of the spacer bond has a specific group, wherein the spacer comprises an oligomer or a polymer, and the specific group comprises one of the following groups: a chemical functional group, a crosslinking molecule, a sugar , fluorescent molecules, paramagnetic molecules, biomolecules and drugs.

其中,上述寡聚物或高分子包含下列族群中之一者或其任意組合:多元醇(polyols)、聚醚系多元醇(polyether polyols)、聚酯類多元醇(polyester polyols)、聚碳酸酯多元醇(polycarbonate polyols)、聚環己內酯多元醇(polycaprolactone polyols)、壓克力多元醇(polyacrylate polyols)、聚乙二醇(polyethylene glycol;PEG)、糊精(dextran)及其共聚物。Wherein the above oligomer or polymer comprises one of the following groups or any combination thereof: polyols, polyether polyols, polyester polyols, polycarbonate Polycarbonate polyols, polycaprolactone polyols, polyacrylate polyols, polyethylene glycol (PEG), dextran, and copolymers thereof.

於本實施例之另一較佳範例中,上述螢光金奈米團簇更包含一間隔物,上述間隔物鍵結上述二氫硫辛酸(dihydrolipoic acid;DHLA)配體,且上述間隔物本身具有一特定基團,其中,上述間隔物包含下列族群中之一者:化學官能基、交聯分子、醣類、螢光分子、順磁性分子、生物分子與藥物。In another preferred embodiment of the present embodiment, the fluorescent gold nano cluster further comprises a spacer, the spacer is bonded to the dihydrolipoic acid (DHLA) ligand, and the spacer itself There is a specific group, wherein the spacer comprises one of the following groups: a chemical functional group, a crosslinking molecule, a saccharide, a fluorescent molecule, a paramagnetic molecule, a biomolecule, and a drug.

本發明之再一實施例係揭露一種螢光金奈米團簇聚集體(Fluorescent gold nanocluster matrix),上述螢光金奈米團簇聚集體係由複數個金奈米團簇規則堆疊所形成,上述金奈米團簇粒徑範圍為0.5nm至3nm,且上述金奈米團簇表面具有一種烷硫醇(alkanethiol)配體(ligand),其中,各個上述金奈米團簇係透過其表面之烷硫醇配體間之作用力,相互吸引堆疊以形成上述螢光金奈米團簇聚集體(Fluorescent gold nanocluster matrix),並且,上述螢光金奈米團簇聚集體係藉由上述金奈米團簇之聚集產生螢光性質,此外,上述螢光金奈米團簇聚集體之光激螢光波長範圍為400至1000nm。According to still another embodiment of the present invention, a fluorescent gold nanocluster matrix is disclosed, wherein the fluorescent gold nano cluster assembly system is formed by stacking a plurality of gold nano clusters. The Jinnai cluster has a particle size ranging from 0.5 nm to 3 nm, and the above-mentioned Jinnai cluster has an alkanethiol ligand, wherein each of the above-mentioned gold nanoclusters passes through the surface thereof. The interaction between the alkanethiol ligands attracts the stacks to form the above-mentioned Fluorescent gold nanocluster matrix, and the above-mentioned fluorescent gold nano cluster assembly system is made up of the above-mentioned gold nanoparticles. The aggregation of the clusters produces a fluorescent property, and in addition, the above-mentioned fluorescent gold nanoparticle aggregates have a wavelength of light-emitting fluorescence ranging from 400 to 1000 nm.

於本實施例之一較佳範例中,上述螢光金奈米團簇聚集體表面包覆一間隔物,上述間隔物之一端鍵結上述烷硫醇配體,且上述間隔物之另一端鍵結有一特定基團,其中,上述間隔物包含兩性高分子或寡聚物,而特定基團包含下列族群中之一者:化學官能基、交聯分子、醣類、螢光分子、順磁性分子、生物分子與藥物等。In a preferred embodiment of the present embodiment, the surface of the fluorescent gold nano-clustered aggregate is coated with a spacer, one end of the spacer is bonded to the alkanethiol ligand, and the other end of the spacer is bonded. A specific group is formed, wherein the spacer comprises an amphoteric polymer or oligomer, and the specific group comprises one of the following groups: a chemical functional group, a crosslinking molecule, a saccharide, a fluorescent molecule, a paramagnetic molecule , biomolecules and drugs.

上述兩性高分子或寡聚物包含下列族群中之一者或其任意組合:聚順丁烯二酸酐[poly(maleic anhydride);PMA]、1-十八烯馬來酸酐的聚合物[Poly(maleic anhydride-alt-1-octadecene);PMAO]與聚丙烯酸(polyacrylic acid;PAA)及其衍生物。The above amphoteric polymer or oligomer comprises one of the following groups or any combination thereof: poly (maleic anhydride); PMA], polymer of 1-octadecene maleic anhydride [Poly ( Maleic anhydride-alt-1-octadecene); PMAO] with polyacrylic acid (PAA) and its derivatives.

於本實施例之另一較佳範例中,螢光金奈米團簇聚集體表面包覆一間隔物,上述間隔物鍵結上述烷硫醇(alkanethiol)配體,且上述間隔物本身具有一特定基團,其中,上述間隔物包含下列族群中之一者:化學官能基、交聯分子、醣類、螢光分子、順磁性分子、生物分子與藥物。In another preferred embodiment of the present embodiment, the surface of the fluorescent gold nanoparticle aggregate is coated with a spacer, the spacer is bonded to the alkanethiol ligand, and the spacer itself has a spacer A specific group, wherein the spacer comprises one of the following groups: a chemical functional group, a crosslinking molecule, a saccharide, a fluorescent molecule, a paramagnetic molecule, a biomolecule, and a drug.

本發明之另一實施例係揭露一種金屬奈米團簇(metal nanocluster)之形成方法,首先提供一混合溶液,上述混合溶液包含一第一金屬前驅物(metal precursor)、一界面活性劑(surfactant)、一還原劑(reductant)與一溶劑,於上述混合溶液中進行一還原反應以形成一奈米金屬粒子(metal nanoparticle),其中,上述奈米金屬粒子具有表面電漿吸收之性質。Another embodiment of the present invention discloses a method for forming a metal nanocluster. First, a mixed solution is provided. The mixed solution comprises a first metal precursor, a surfactant (surfactant). And a reducing agent and a solvent are subjected to a reduction reaction in the mixed solution to form a metal nanoparticle, wherein the nano metal particles have a surface plasma absorption property.

再者,於形成上述奈米金屬粒子後加入一第二金屬前驅物,使得上述第二金屬前驅物之粒子數大於上述奈米金屬粒子之總數,由於上述奈米金屬粒子與上述第二金屬前驅物之濃度差異甚大,造成一不平衡之並存系統,上述奈米金屬粒子因此崩裂為粒徑較小之金屬奈米團簇(metal nanocluster)以形成一平衡系統,其中,上述金屬奈米團簇之粒徑範圍係為1nm至4nm。Furthermore, after forming the nano metal particles, a second metal precursor is added, so that the number of particles of the second metal precursor is greater than the total number of the nano metal particles, because the nano metal particles and the second metal precursor are The concentration of the substance is very different, resulting in an unbalanced coexisting system. The above-mentioned nano metal particles are thus broken into metal nanoclusters having a smaller particle size to form a balance system, wherein the above metal nanoclusters The particle size ranges from 1 nm to 4 nm.

此外,上述第一金屬前驅物與第二金屬前驅物係能為相同或不同,其中,上述第一金屬前驅物(metal precursor)與第二金屬前驅物係選自下列族群之一者:氯化金(AuCl3 )、四氯金酸(HAuCl4 )、溴化金(AuBr3 )、四溴金酸(HAuBr4 )。Furthermore, the first metal precursor and the second metal precursor may be the same or different, wherein the first metal precursor and the second metal precursor are selected from one of the following groups: chlorination Gold (AuCl 3 ), tetrachloroauric acid (HAuCl 4 ), gold bromide (AuBr 3 ), tetrabromoic acid (HAuBr 4 ).

而上述界面活性劑(surfactant)係選自下列族群之一者或其任意組合:雙十二烷基二烷基溴化銨鹽(Didodecyldimethylammonium bromide;DDAB)、四辛基溴化銨(Tetraoctylammonium bromide;TOAB)、四丁基溴化銨(Tetrabutylammonium bromide;TBAB)。還原劑(reductant)則選自下列族群之一者或其任意組合:四丁基溴化銨(tetrabutylammonium borohydride;TBAB)、硼氫化鈉(NaBH4 )、維生素C(Ascorbic Acid)。溶劑則係為甲苯(toluene)或氯仿(chloroform)。The above surfactant is selected from one of the following groups or any combination thereof: didodecyldimethylammonium bromide (DDAB), tetraoctyl ammonium bromide (Tetraoctylammonium bromide; TOAB), Tetrabutylammonium bromide (TBAB). The reductant is selected from one of the following groups or any combination thereof: tetrabutylammonium borohydride (TBAB), sodium borohydride (NaBH 4 ), and vitamin C (Ascorbic Acid). The solvent is toluene or chloroform.

另一方面,於形成上述金屬奈米團簇後進行一配體接合(Ligand-binding)反應,上述反應係將配體(ligand)接合於上述金屬奈米團簇之表面,以形成一配體包覆之金屬奈米團簇(ligand-capped metal nanocluster)。On the other hand, after forming the above-mentioned metal nanoclusters, a Ligand-binding reaction is carried out, and the above-mentioned reaction is to bond a ligand to the surface of the above-mentioned metal nanoclusters to form a ligand. Lagged-capped metal nanocluster.

而上述配體(ligand)係選自下列族群之一者:二氫硫辛酸(dihydrolipoic acid;DHLA)、十二烷硫醇 (dodecanethiol;DDT)、雙(磺酸鈉苯基)苯基磷[Bis(p-sulfonatophenyl)phenylphosphine;BSPP]、三苯基磷(triphenylphosphine)。The above ligand is selected from one of the following groups: dihydrolipoic acid (DHLA), dodecanethiol (dodecanethiol; DDT), bis(p-sulfonatophenyl)phenylphosphine; BSPP], triphenylphosphine.

再者,上述配體接合(Ligand-binding)反應係為一硫醇配體接合(thiol-related ligand binding)反應,上述反應係將上述硫醇配體(thiol-related ligand)接合於上述金屬奈米團簇之表面,以形成一硫醇配體包覆之金屬奈米團簇(thiol-capped metal nanocluster)。Furthermore, the above Ligand-binding reaction is a thiol-related ligand binding reaction, and the above reaction is to bond the above thiol-related ligand to the above-mentioned metal naphthalene. The surface of the rice clusters forms a thiol-capped metal nanocluster.

上述硫醇配體(thiol-related ligand)係選自下列族群之一者:二氫硫辛酸(dihydrolipoic acid;DHLA)、十二烷硫醇(dodecanethiol;DDT)、雙硫醇琥珀酸(meso-2,3-dimercaptosuccinic acid;DMSA)、穀胱甘肽(glutathione;GSH)、1,6-己二硫醇(1,6-hexanedithiol)。The above thiol-related ligand is selected from one of the following groups: dihydrolipoic acid (DHLA), dodecanethiol (DDT), dithiol succinic acid (meso-) 2,3-dimercaptosuccinic acid; DMSA), glutathione (GSH), 1,6-hexanedithiol (1,6-hexanedithiol).

其中,上述硫醇包覆之金屬奈米團簇(thiol-capped metal nanocluster)係為一螢光金屬奈米團簇(Fluorescent metal nanocluster),上述螢光金屬奈米團簇之粒徑範圍係為0.5nm至3nm。Wherein the thiol-capped metal nanocluster is a fluorescent metal nanocluster, and the particle size range of the fluorescent metal nano cluster is 0.5 nm to 3 nm.

並且,於形成上述螢光金屬奈米團簇(Fluorescent metal nanocluster)後進行一官能基披覆(functional coating)反應,以使得上述螢光金屬奈米團簇具有至少一官能基特性,其中,上述官能基披覆(functional coating)反應係為一生物接枝(Bioconjugation)反應。And, after forming the above-mentioned Fluorescent metal nanocluster, performing a functional group coating (functional The reaction is such that the above-mentioned fluorescent metal nanoclusters have at least one functional group property, wherein the functional group coating reaction is a bioconjugation reaction.

上述官能基披覆(functional coating)反應之官能基係選自下列族群之一者:化學官能基、交聯分子、醣類、螢光分子、順磁性分子、生物分子與藥物。The functional group of the above functional coating reaction is selected from one of the following groups: a chemical functional group, a crosslinking molecule, a saccharide, a fluorescent molecule, a paramagnetic molecule, a biomolecule, and a drug.

根據以上所述之實施例,上述螢光金奈米團簇與螢光金奈米團簇聚集體(Fluorescent gold nanocluster matrix)等螢光金屬奈米團簇係能作為生物探針(bioprobes),並具有下列之應用:生物螢光標記(fluorescent biological label)、臨床醫療影像顯影劑以及臨床醫療檢測、追蹤與治療。According to the above embodiments, the fluorescent metal nano clusters such as the fluorescent gold nano clusters and the fluorescent gold nanocluster matrix can be used as bioprobes. It has the following applications: fluorescent biological label, clinical medical imaging developer, and clinical medical testing, tracking and treatment.

範例一 螢光金奈米團簇Example 1 Fluorescent Golden Nano Cluster (一)螢光金奈米團簇AuNC-DHLA之製備(1) Preparation of fluorescent gold nano cluster AuNC-DHLA

(I)首先,將雙十二烷基二烷基溴化銨鹽溶於甲苯用以作為預製備溶液(100mM),其次,將氯化金或四溴金酸溶於雙十二烷基二烷基溴化銨鹽中(25mM)以形成一金屬金前驅溶液,接著,混合0.625mL癸酸與1mL的預製備溶液並予攪拌,隨後於攪拌同時再注入0.8mL金屬金前驅溶 液,以獲得一暗紅色溶液,其中,加入過量之甲醇直到暗紅色溶液變成不透明之藍紫色溶液,藉由甲醇誘使金奈米粒子聚集,此外,使用離心機將溶液中未反應之剩餘反應試劑以及過小之金奈米粒子移除。(I) First, the dodecyldialkylammonium bromide salt is dissolved in toluene for use as a pre-preparation solution (100 mM), and secondly, gold chloride or tetrabromogold acid is dissolved in the dodecyl group. In the alkylammonium bromide salt (25 mM) to form a metal gold precursor solution, then mix 0.625 mL of citric acid with 1 mL of the pre-prepared solution and stir, then re-inject 0.8 mL of metal gold before stirring. Liquid to obtain a dark red solution in which an excess of methanol is added until the dark red solution becomes an opaque blue-violet solution, and the gold nanoparticles are induced to accumulate by methanol, and further, the unreacted residual reaction in the solution is measured using a centrifuge. Reagents and too small gold nanoparticles are removed.

將純化後之金奈米粒子再次溶解於雙十二烷基二烷基溴化銨鹽溶液中以形成一暗紅色溶液,其次,再加入金屬金前驅溶液並持續攪拌,直到暗紅色溶液轉為淡黃色透明液體。此時,上述金奈米粒子已崩裂為粒徑較小之金奈米團簇。其中,上述金奈米粒子具有表面電漿性質(520-530nm),而金奈米團簇則無此性質,其吸收光譜如第一圖所示,其中,以氯化金作為第一金屬前驅物,並且,(A)為金奈米粒子;(B)為使用氯化金作為第二金屬前驅物之金奈米團簇;(C)為使用四溴金酸為第二金屬前驅物之金奈米團簇。The purified gold nanoparticle is redissolved in the dodecyldialkylammonium bromide salt solution to form a dark red solution, and secondly, the metal gold precursor solution is added and stirring is continued until the dark red solution is turned into Light yellow transparent liquid. At this time, the above-mentioned gold nanoparticles have been broken into clusters of gold nanoparticles having a small particle size. Wherein, the above-mentioned gold nanoparticles have surface plasma properties (520-530 nm), while the gold nano-clusters have no such properties, and the absorption spectrum thereof is as shown in the first figure, wherein gold chloride is used as the first metal precursor. And (A) is a gold nanoparticle; (B) is a gold nanoparticle using gold chloride as a second metal precursor; (C) is a second metal precursor using tetrabromoic acid Jinnai clusters.

(II)0.0322g四丁基溴化銨粉末溶於2.5mL的雙十二烷基二烷基溴化銨鹽溶液,直至粉末完全溶解。再將0.052g硫辛酸(lipoic acid)加入上述溶液中,直至溶液沒有氣泡產生,使得硫辛酸還原成二氫硫辛酸,其中,為避免硫辛酸還原不完全,因此再加入過量之還原劑四丁基溴化銨粉末,確定已無氣泡產生。再者,將2.5mL金奈米團簇溶液混入二氫硫辛酸溶液中並持續攪拌,此時,上述混合溶液會轉為不透明並呈現為黃棕色,據此形成螢光金奈 米團簇。(II) 0.0322 g of tetrabutylammonium bromide powder was dissolved in 2.5 mL of the dodecyldialkylammonium bromide salt solution until the powder was completely dissolved. Then add 0.052g of lipoic acid to the above solution until no bubbles are generated in the solution, so that the lipoic acid is reduced to dihydrolipoic acid. In order to avoid incomplete reduction of lipoic acid, an excess of reducing agent is added. The ammonium bromide powder was determined to have no bubble generation. Furthermore, 2.5 mL of the gold nano-cluster solution is mixed into the dihydrolipoic acid solution and continuously stirred. At this time, the mixed solution turns opaque and appears yellow-brown, thereby forming a fluorescent Chennai. Rice clusters.

其中,螢光金奈米團簇AuNC-DHLA之吸收(absorption)、光激螢光(photoluminescence;PL)、光激發螢光.(photoluminescence excitation;PLE)之光譜圖,如第二圖所示。Among them, the spectrum of absorption, photoluminescence (PL), and photoluminescence excitation (PLE) of the fluorescent gold nano cluster AuNC-DHLA is shown in the second figure.

(二)螢光金奈米團簇生物分子接枝(2) Fluorescent gold nano-cluster biomolecule grafting

首先,取10μl螢光金奈米團簇溶液與10μl X-PEG-amine(3mM in ddH2O)均勻混合形成一混合溶液,接著,加入1-ethyl-3-(3-dimethylaminopropyl)carbodiimide溶液(EDC,8mM in ddH2O),震盪反應兩小時,據此完成一生物分子接枝反應,其中,上述之PEG係能為維生素(biotin)或卵白素(avidin),上述生物分子接枝反應示意圖如第三圖所示。此外,將改質之螢光金奈米團簇以膠體電泳方式(2% agarose,75V)進行純化,以100kDa分子篩離心置換於SBB(sodium borate buffer,pH=9)中。First, 10 μl of fluorescent gold nano cluster solution was uniformly mixed with 10 μl of X-PEG-amine (3 mM in ddH 2 O) to form a mixed solution, followed by addition of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide solution (EDC, 8mM in ddH2O), shaking reaction for two hours, according to which a biomolecule grafting reaction is completed, wherein the above PEG system can be vitamin (biotin) or avidin (avidin), and the above-mentioned biomolecule grafting reaction diagram is as shown in the third figure. Shown. In addition, the modified fluorescent gold nanocapsules were purified by colloidal electrophoresis (2% agarose, 75 V) and centrifuged in SBB (sodium borate buffer, pH=9) with a 100 kDa molecular sieve.

範例二 螢光金奈米團簇聚集體Example 2 Fluorescent gold nano cluster aggregates (一)螢光金奈米團簇AuNC-DDT之製備(1) Preparation of fluorescent gold nano cluster AuNC-DDT

提供一種金奈米團簇溶液,其形成方法如範例一(I)所述。將上述金奈米團簇溶液持續攪拌10分鐘,將其緩慢滴入帶有硫醇基之碳鏈分子十二烷硫醇溶液中(體積比為1:1),攪拌1小時,進行粒子表面配位基修飾置換,此時溶液產生明顯之混濁現象,據此,形成螢光金奈米團簇聚集體。A gold nanocluster solution is provided, which is formed as described in Example I(I). The above-mentioned gold nano-cluster solution was continuously stirred for 10 minutes, and slowly dropped into a solution of a thiol group-containing carbon chain molecule dodecanethiol (1:1 by volume), and stirred for 1 hour to carry out particle surface. The ligand is modified and replaced, and at this time, the solution produces a significant turbidity, whereby luminescent nano-nano cluster aggregates are formed.

(二)螢光金奈米團簇生物分子接枝(2) Fluorescent gold nano-cluster biomolecule grafting

取200μl螢光金奈米團簇溶液與200μl半乳糖溶液(80mM in ddH2 O)混合均勻,加入1-ethyl-3-(3-dimethylaminopropyl)carbodiimide(EDC,30mM in ddH2 O)交聯劑溶液,震盪反應兩小時,利用EDC與帶胺基半乳糖所產生之醯胺鍵結,將半乳糖分子接枝於螢光金奈米團簇表面,以100kDa分子篩離心,除去過量之半乳糖。200 μl of fluorescent gold nano cluster solution was mixed with 200 μl of galactose solution (80 mM in ddH 2 O), and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, 30 mM in ddH 2 O) crosslinking agent was added. The solution was shaken for two hours, and the galactose molecule was grafted onto the surface of the fluorescent gold nanoparticle cluster by EDC and the indoleamine bond with the amine galactose, and centrifuged at 100 kDa molecular sieve to remove excess galactose.

其中,取20μl接枝後之螢光半乳糖金奈米團簇,與20μl凝集素RCA120(1mg/ml)混合均勻,反應20分鐘,觀察凝集反應是否發生,以判定半乳糖分子是否成功接枝至螢光金團簇表面。此外,將改質後之螢光金奈米團簇以膠體電泳方式(2% agarose,75V)進行純化,經透析膜回收後,以100kDa分子篩離心置換於SBB(sodium borate buffer,pH=9)中。第六圖所示即為以兩性高分 子改質之具烷硫醇配體的螢光金奈米團簇聚集體示意圖。Among them, 20 μl of the grafted galactose-galactin cluster was mixed with 20 μl of lectin RCA120 (1 mg/ml), and reacted for 20 minutes to observe whether agglutination occurred or not to determine whether the galactose molecule was successfully grafted. To the surface of the fluorescent gold cluster. In addition, the modified fluorescent gold nano-clusters were purified by colloidal electrophoresis (2% agarose, 75V), recovered by dialysis membrane, and centrifuged in SBB (sodium borate buffer, pH=9) with 100kDa molecular sieve. in. The sixth picture shows the high scores Schematic representation of a sub-modified agglomerate of fluorescent gold nanoclusters with an alkanethiol ligand.

經由統計分析發現,吸收光譜上升趨勢與螢光光譜相符,顯示Au-DDT團簇之螢光特性與團簇產生自組裝(self-assemble)之聚集程度有關,隨Au-S鍵結的產生,團簇組裝結構愈趨明顯而導致螢光產生且強度增強,其中,分別以325nm、345nm及365nm波長激發光激發Au-DDT螢光團簇,皆在600nm產生紅色放射螢光,且波峰並無產生位移,表示Au-DDT團簇的紅光為螢光特性,而非一般散射光;此外,將放射光分別固定在580nm及600nm,測量最適合之螢光激發光波長,發現兩者皆在325nm位置產生峰值,顯示Au-DDT螢光金團簇以325nm波長進行激發,能在600nm得到最大強度之紅色螢光放射,如第四圖所示。Through statistical analysis, it is found that the upward trend of the absorption spectrum is consistent with the fluorescence spectrum, indicating that the fluorescence characteristics of the Au-DDT cluster are related to the degree of self-assemble aggregation of the cluster. With the generation of Au-S bonds, As the cluster assembly structure becomes more and more obvious, the fluorescence is generated and the intensity is enhanced. Among them, the Au-DDT fluorescent clusters are excited by the excitation light at 325 nm, 345 nm and 365 nm wavelengths respectively, and the red emission fluorescence is generated at 600 nm, and the peaks are not present. A displacement is generated, indicating that the red light of the Au-DDT cluster is a fluorescent characteristic rather than a general scattered light; in addition, the emitted light is fixed at 580 nm and 600 nm, respectively, and the wavelength of the most suitable fluorescent excitation light is measured, and both are found. A peak is generated at the 325 nm position, indicating that the Au-DDT fluorescent gold cluster is excited at a wavelength of 325 nm, and the maximum intensity of red fluorescent radiation can be obtained at 600 nm, as shown in the fourth figure.

參考第五圖所示,HAuCl4 precursor在370nm具有特性吸收峰,經TBAB還原劑作用後產生6nm之奈米金粒子,在520nm出現表面電漿共振吸收峰;繼續加入HAuCl4 溶液,使奈米金粒子崩解成團簇,520nm吸收峰消失,表示團簇小於5nm,除了原HAuCl4 在370nm之峰值出現,在310nm產生新的吸收峰,最後加入DDT分子產生螢光金團簇Au-DDT,因碳鏈分子間彼此之疏水性作用,使團簇形成自組裝結構,吸收光譜在紅外光範圍明顯增加,足見聚集作用之產生。其中,金奈米粒子與金奈米團簇各階段 合成過程產物之吸收光譜:(A)HAuCl4 precursor(0.625mM)(B)奈米金粒子(C)金奈米團簇(D)AuNC-DDT螢光奈米金粒子團簇。Referring to the fifth figure, the HAuCl 4 precursor has a characteristic absorption peak at 370 nm, and 6 nm nano gold particles are generated by the TBAB reducing agent, and a surface plasma resonance absorption peak appears at 520 nm; the HAuCl 4 solution is continuously added to make the nano The gold particles disintegrated into clusters, and the absorption peak at 520 nm disappeared, indicating that the cluster was less than 5 nm. Except that the original HAuCl 4 appeared at the peak of 370 nm, a new absorption peak was generated at 310 nm, and finally DDT molecules were added to produce a fluorescent gold cluster Au-DDT. Due to the hydrophobic interaction between the carbon chain molecules, the clusters form a self-assembled structure, and the absorption spectrum is significantly increased in the infrared range, which indicates that the aggregation occurs. Among them, the absorption spectra of the products of the various stages of the synthesis of the gold nanoparticles and the gold nanoparticles: (A) HAuCl 4 precursor (0.625 mM) (B) nano gold particles (C) gold nano clusters (D) AuNC -DDT fluorescent nano gold clusters.

顯然地,依照上面實施例中的描述,本發明可能有許多的修正與差異。因此需要在其附加的權利要求項之範圍內加以理解,除了上述詳細的描述外,本發明還可以廣泛地在其他的實施例中施行。上述僅為本發明之較佳實施例而已,並非用以限定本發明之申請專利範圍;凡其它未脫離本發明所揭示之精神下所完成的等效改變或修飾,均應包含在下述申請專利範圍內。Obviously, many modifications and differences may be made to the invention in light of the above description. It is therefore to be understood that within the scope of the appended claims, the invention may be The above are only the preferred embodiments of the present invention, and are not intended to limit the scope of the claims of the present invention; all other equivalent changes or modifications which are not departing from the spirit of the present invention should be included in the following claims. Within the scope.

第一圖為本發明之範例一中,金奈米粒子與金奈米團簇之吸收光譜;第二圖為本發明之範例一中,螢光金奈米團簇AuNC-DHLA之吸收(absorption)、光激螢光(photoluminescence;PL)、光激發螢光(photoluminescence excitation;PLE)之光譜圖;第三圖為本發明之範例一中,螢光金奈米團簇AuNC-DHLA生物分子接枝反應示意圖;第四圖為本發明之範例二中,螢光金團簇AuNC-DDT之光激發螢光光譜(PLE)與光激發光譜(PL);第五圖為本發明之範例二中,金奈米粒子與螢光金奈米團簇AuNC-DDT之吸收光譜;與 第六圖為本發明之範例二中,以兩性高分子改質之具烷硫醇配體的螢光金奈米團簇聚集體示意圖。The first figure is the absorption spectrum of the gold nanoparticles and the gold nano clusters in the first example of the present invention; the second figure is the absorption of the fluorescent gold nano cluster AuNC-DHLA in the first example of the present invention (absorption) ), photoluminescence (PL), photoluminescence excitation (PLE) spectrum; third diagram is the first example of the invention, fluorescent gold nano cluster AuNC-DHLA biomolecule Schematic diagram of the branch reaction; the fourth figure is the photoexcited fluorescence spectrum (PLE) and photoexcitation spectrum (PL) of the fluorescent gold cluster AuNC-DDT in the second example of the present invention; the fifth figure is in the second example of the present invention. , absorption spectra of gold nanoparticles and fluorescent gold nanoclusters AuNC-DDT; Fig. 6 is a schematic view showing the aggregate of fluorescent gold nanoclusters having an alkanethiol ligand modified by an amphoteric polymer in the second embodiment of the present invention.

Claims (6)

一種螢光金奈米團簇聚集體,該螢光金奈米團簇聚集體係由複數個金奈米團簇規則堆疊所形成,該金奈米團簇粒徑範圍為0.5nm至3nm,且該金奈米團簇表面具有一種烷硫醇配體(ligand),其中,各個該金奈米團簇係透過其表面之烷硫醇配體間之作用力,相互吸引堆疊以形成該螢光金奈米團簇聚集體,並且,該螢光金奈米團簇聚集體係藉由該金奈米團簇之聚集體產生螢光,其中,該螢光金奈米團簇聚集體之光激螢光波長為600nm。 A fluorescent gold nano-aggregate aggregate formed by a regular stack of a plurality of gold nanoclusters having a particle size ranging from 0.5 nm to 3 nm, and The surface of the gold nanoclusters has an alkanethiol ligand, wherein each of the golden nanoclusters is attracted to each other through a force between the alkanethiol ligands on the surface thereof to form the fluorescent light. a gold nano-aggregate aggregate, and the fluorescent gold nano-aggregate aggregation system generates fluorescence by the aggregate of the golden nano-clusters, wherein the fluorescent gold nano-aggregate aggregate is light-excited The fluorescence wavelength is 600 nm. 如申請專利範圍第1項所述之螢光金奈米團簇聚集體,其中,於該螢光金奈米團簇聚集體表面包覆一間隔物,該間隔物之一端鍵結該烷硫醇配體,且該間隔物之另一端鍵結有一特定基團。 The fluorescent gold nano-clustered aggregate according to claim 1, wherein a surface of the fluorescent gold nano-aggregate aggregate is coated with a spacer, and one end of the spacer is bonded to the alkyl sulfide. An alcohol ligand, and the other end of the spacer is bonded to a specific group. 如申請專利範圍第2項所述之螢光金奈米團簇聚集體,其中,該間隔物包含兩性高分子或寡聚物。 The fluorescent gold nanoparticle aggregate according to claim 2, wherein the spacer comprises an amphoteric polymer or an oligomer. 如申請專利範圍第3項所述之螢光金奈米團簇聚集體,其 中,該兩性高分子或寡聚物包含下列族群中之一者或其任意組合:聚順丁烯二酸酐[poly(maleic anhydride);PMA]、1-十八烯馬來酸酐的聚合物[Poly(maleic anhydride-alt-1-octadecene);PMAO]與聚丙烯酸(polyacrylic acid;PAA)。 a fluorescent gold nano-aggregate aggregate as described in claim 3, The amphoteric polymer or oligomer comprises one of the following groups or any combination thereof: poly (maleic anhydride); PMA], a polymer of 1-octadecene maleic anhydride [ Poly(maleic anhydride-alt-1-octadecene); PMAO] and polyacrylic acid (PAA). 如申請專利範圍第2項所述之螢光金奈米團簇聚集體,其中,該特定基團係包含下列族群中之一者:化學官能基、交聯分子、醣類、螢光分子、順磁性分子、生物分子與藥物等。 The fluorescent gold nano-clustered aggregate according to claim 2, wherein the specific group comprises one of the following groups: a chemical functional group, a crosslinking molecule, a saccharide, a fluorescent molecule, Paramagnetic molecules, biomolecules and drugs. 如申請專利範圍第1項所述之螢光金奈米團簇聚集體,其中,該螢光金奈米團簇聚集體係能作為生物探針(bioprobes),並具有下列之應用:生物螢光標記(fluorescent biological label)、臨床醫療影像顯影劑、以及臨床醫療檢測、追蹤與治療。 The fluorescent gold nano cluster aggregate according to claim 1, wherein the fluorescent gold nano cluster aggregation system can be used as a bioprobe and has the following applications: biological fluorescence Fluorescent biological label, clinical medical imaging developer, and clinical medical testing, tracking and treatment.
TW100149309A 2008-08-29 2008-08-29 Fluorescent gold nanocluster matrix TWI438005B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW100149309A TWI438005B (en) 2008-08-29 2008-08-29 Fluorescent gold nanocluster matrix

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW100149309A TWI438005B (en) 2008-08-29 2008-08-29 Fluorescent gold nanocluster matrix

Publications (2)

Publication Number Publication Date
TW201223546A TW201223546A (en) 2012-06-16
TWI438005B true TWI438005B (en) 2014-05-21

Family

ID=46725581

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100149309A TWI438005B (en) 2008-08-29 2008-08-29 Fluorescent gold nanocluster matrix

Country Status (1)

Country Link
TW (1) TWI438005B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103820114B (en) * 2014-03-04 2016-02-03 东南大学 The preparation method of a kind of fluorescence nano based on rare earth metal cerium bunch and application thereof
CN111117302A (en) * 2019-12-17 2020-05-08 Tcl华星光电技术有限公司 Nano dye molecule, color filter and display panel
US11453781B2 (en) 2019-12-17 2022-09-27 Tcl China Star Optoelectronics Technology Co., Ltd. Nano dye molecule, color filter, and display panel

Also Published As

Publication number Publication date
TW201223546A (en) 2012-06-16

Similar Documents

Publication Publication Date Title
TWI361081B (en) Fluorescent gold nanocluster and method for forming the same
Goswami et al. Highly luminescent thiolated gold nanoclusters impregnated in nanogel
Zhang et al. Surface-enhanced fluorescence of fluorescein-labeled oligonucleotides capped on silver nanoparticles
Zhao et al. Developing fluorescent copper nanoclusters: Synthesis, properties, and applications
He et al. An overview of recent advances in quantum dots for biomedical applications
Nie et al. Applications of gold nanoparticles in optical biosensors
Panthi et al. Synthesis of metal nanoclusters and their application in Hg2+ ions detection: A review
Cui et al. Controllable metal-enhanced fluorescence in organized films and colloidal system
Mandal et al. Influence of acid on luminescence properties of thioglycolic acid-capped CdTe quantum dots
Li et al. Nanoparticle-based electrochemiluminescence cytosensors for single cell level detection
Liu et al. Studies on CdSe/L-cysteine quantum dots synthesized in aqueous solution for biological labeling
Qi et al. Electrochemical methods to study photoluminescent carbon nanodots: preparation, photoluminescence mechanism and sensing
Pan et al. Effects of carbon nanotubes on photoluminescence properties of quantum dots
Alizadeh‐Ghodsi et al. State‐of‐the‐Art and Trends in Synthesis, Properties, and Application of Quantum Dots‐Based Nanomaterials
US20090042032A1 (en) Novel water-soluble nanocrystals comprising a low molecular weight coating reagent, and methods of preparing the same
Farzin et al. Biosensing strategies based on organic-scaffolded metal nanoclusters for ultrasensitive detection of tumor markers
Goryacheva et al. Synthesis and bioanalytical applications of nanostructures multiloaded with quantum dots
Xing et al. Specific detection of carcinoembryonic antigen based on fluorescence quenching of hollow porous gold nanoshells with roughened surface
Huang et al. Facile preparation of highly blue fluorescent metal nanoclusters in organic media
Farshchi et al. Nanomaterial based aptasensing of prostate specific antigen (PSA): recent progress and challenges in efficient diagnosis of prostate cancer using biomedicine
Pichaandi et al. Long-term colloidal stability and photoluminescence retention of lead-based quantum dots in saline buffers and biological media through surface modification
Clarke et al. Effect of ligand density on the spectral, physical, and biological characteristics of CdSe/ZnS quantum dots
Xia Optical sensing and biosensing based on non-spherical noble metal nanoparticles
CN109181678B (en) Method for synthesizing green fluorescent gold nanocluster stabilized by mercapto-beta-cyclodextrin and application of green fluorescent gold nanocluster
Granada-Ramírez et al. Quantum dots for biomedical applications